Mabpharm Limited - Share Issue/Capital Change 2019

This Application Form uses the same terms as defined in the prospectus of Mabpharm Limited (the “Company”) dated May 20, 2019 (the “Prospectus”). 本申請表格使用邁博藥業有限公司（「本公司」）於 2019 年 5 月 20 日刊發的招股章程（「招股章程」）所界定的詞語。 Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any Staple your jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offeredor sold in the United States without registration or an exemption from registration under the U.S. Securities Act. 本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根據美國證券法登記或豁 payment here 免登記，香港發售股份不得在美國提呈發售或出售。 請將股款 This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 緊釘在此 在任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得以任何方式發送或派發或轉載（不論全部或部分）本申請表格及招股章程。 Copies of the Prospectus, all related Application Forms and the other documents specified in the paragraph headed “1. Documents delivered to the Registrar of Companies” in Appendix V to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), Hong Kong Securities Clearing Company Limited (“HKSCC”), the Securities and Futures Commission of Hong Kong (the “SFC”) and the Registrar of Companies in Hong Kong take no responsibility for the contents of these documents. 招股章程、所有相關申請表格及招股章程附錄五「1. 送呈公司註冊處處長文件」一段所述其他文件已按香港法例第 32 章公司（清盤及雜項條文）條例第 342C 條規定送呈香港公司註冊處處長登記。香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）、香港中央結算有限公司（「香港結算」）、香港證券及期貨事務監察委員會（「證監會」）及香港公司註冊處處長對此等文件的內容概不負責。 Mabpharm Limited 邁博藥業有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） Stock code : 2181 股份代號 : 2181 Maximum Offer Price : HK$1.95 per Offer Share, plus brokerage fee of 1.0%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) (If the Offer Price is set at 10% below the bottom end of the indicative Offer Price after making a Downward Offer Price Adjustment, the Offer Price will be HK$1.35 per Hong Kong Offer Share) 最高發售價 : 每股發售股份 1.95 港元，另加 1.0% 經紀佣金、0.0027% 證監會交易徵費及 0.005% 聯交所交易費（須於申請時以港元繳足，多繳股款可予退還）（如按發售價下調機制將發售價下調至指示性發售價範圍下限的 10% 以下，發售價將為每股發售股份 1.35 港元） You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. ，一。招股章程尚有關於申請程序的其他資料本申請表格應與招股章程併閱讀 Application Form 申請表格 To: Mabpharm Limited 致：邁博藥業有限公司 Sole Global Coordinator 獨家全球協調人 Sole Sponsor 獨家保薦人 Sole Bookrunner 獨家賬簿管理人 The Hong Kong Underwriter 香港包銷商

申請人聲明

Applicants’ declaration

本人╱吾等同意本申請表格及招股章程的條款及條件以及申請程序。請參閱本申請表格「填交本申請表格的效用」一節。

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

警告：任何人士僅限作出一次為其利益而進行的認購申請。請參閱「填交本申請表格的效用」一節最後四點。

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullets of “Effect of completing and submitting this Application Form” section.

Signed by (all) applicant(s) (all joint applicants must sign): For Broker use 此欄供經紀填寫 Lodged by 遞交申請的經紀由（所有）申請人簽署（所有聯名申請人必須簽署）： Broker No. 經紀號碼 Broker’s Chop 經紀印章 Date: 日期 : ╱ ╱ D 日 M 月 Y 年 Number of Hong Kong Offer Shares applied for (not more than 39,178,000 Shares) 申請香港發售股份數目（不超過 39,178,000 股股份） Cheque/banker’s cashier order number 支票╱銀行本票號碼 Name of bank on which cheque/banker’s cashier order is drawn Total amount 總額 (see “How to make your application” section) 兌現支票╱銀行本票的銀行名稱（見「申請手續」一節） HK$ 港元 Name in English (in BLOCK letters) 英文姓名╱名稱（正楷） Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業（以英文填寫） Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. (Please delete as appropriate) 香港身份證號碼╱ 護照號碼╱香港商業登記號碼（請刪除不適用者） Names of all other joint applicants in English (if any) (in Block Letters) Hong Kong Identity Card No./Passport No./Hong Kong Business 所有其他聯名申請人的英文姓名╱名稱（如有）（正楷） Registration No. of all other joint applicants (Please delete as appropriate) 所有其他聯名申請人的香港身份證號碼╱護照號 1) 碼╱香港商業登記號碼（請刪除不適用者） 1) 2) 2) 3) 3) Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only) (in Block Letters) 香港地址（以英文填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼）（正楷） Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an THIS BOX MUST BE DULY COMPLETED account number or identific a tion code for each (joint) beneficial 必須填妥此欄 owner. 由代名人遞交：代名人若不填寫本欄，是項認購申請 Participant I.D. of the CCASS Investor Participant or designated 將視作為閣下利益提出。請填寫每名（聯名）實益擁有人的 CCASS Participant 中央結算系統投資者戶口持有人或指定的中 賬戶號碼或識別編碼。 央結算系統參與者的參與者編號與者編號 ADDRESS LABEL 地址標貼 (Your name(s) and address in For designated CCASS Participant or Corporate CCASS Investor Hong Kong in BLOCK letters 請用正楷填寫 姓名╱名稱 及香港 Participant, please also affix the company chop bearing its company 地址 ) name 指定的中央結算系統參與者或公司中央結算系統公司投資

Participant I.D. of the CCASS Investor Participant or designated CCASS Participant 中央結算系統投資者戶口持有人或指定的中央結算系統參與者的參與者編號與者編號 For designated CCASS Participant or Corporate CCASS Investor Participant, please also affix the company chop bearing its company name 指定的中央結算系統參與者或公司中央結算系統公司投資者戶口持有人，請加蓋顯示公司名稱的公司印鑑

For internal use 此欄供內部使用

(See paragraph 2 in the section “How to make your application”) （請參閱「申請手續」一節第 2 段）

This page is intentionally left blank 此乃白頁特意留空

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected. NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS No. of Amount No. of Amount No. of Amount No. of Amount Hong Kong payable on Hong Kong payable on Hong Kong payable on Hong Kong payable on Offer Shares application Offer Shares application Offer Shares application Offer Shares application applied for HK$ applied for HK$ applied for HK$ applied for HK$ 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) Maximum number of Hong Kong Offer Shares you may apply for. 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. You, as the applicant(s), must complete the form in English (in Block Letters) as indicated below and sign on the second page of the Application Form. Only written signatures will be accepted (and not by way of personal chop). If you are applying through a designated CCASS Participant (other than a CCASS Investor Participant): ‧the designated CCASS Participant must endorse the form with its company chop (bearing its company name) and insert its participant I.D. in the appropriate box. If you are applying as an individual CCASS Investor Participant: ‧the form must contain your NAME and Hong Kong I.D. Card number; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a joint individual CCASS Investor Participant: ‧the form must contain all joint investor participants’ NAMES and the Hong Kong I.D. Card number of all joint investor participants; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a corporate CCASS Investor Participant: ‧the form must contain your company NAME and Hong Kong Business Registration number; ‧your participant I.D. and your company chop (bearing your company name) must be inserted in the appropriate box. S mp e樣版	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected. NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS No. of Amount No. of Amount No. of Amount No. of Amount Hong Kong payable on Hong Kong payable on Hong Kong payable on Hong Kong payable on Offer Shares application Offer Shares application Offer Shares application Offer Shares application applied for HK$ applied for HK$ applied for HK$ applied for HK$ 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) Maximum number of Hong Kong Offer Shares you may apply for. 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. You, as the applicant(s), must complete the form in English (in Block Letters) as indicated below and sign on the second page of the Application Form. Only written signatures will be accepted (and not by way of personal chop). If you are applying through a designated CCASS Participant (other than a CCASS Investor Participant): ‧the designated CCASS Participant must endorse the form with its company chop (bearing its company name) and insert its participant I.D. in the appropriate box. If you are applying as an individual CCASS Investor Participant: ‧the form must contain your NAME and Hong Kong I.D. Card number; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a joint individual CCASS Investor Participant: ‧the form must contain all joint investor participants’ NAMES and the Hong Kong I.D. Card number of all joint investor participants; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a corporate CCASS Investor Participant: ‧the form must contain your company NAME and Hong Kong Business Registration number; ‧your participant I.D. and your company chop (bearing your company name) must be inserted in the appropriate box. S mp e樣版	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected. NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS No. of Amount No. of Amount No. of Amount No. of Amount Hong Kong payable on Hong Kong payable on Hong Kong payable on Hong Kong payable on Offer Shares application Offer Shares application Offer Shares application Offer Shares application applied for HK$ applied for HK$ applied for HK$ applied for HK$ 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) Maximum number of Hong Kong Offer Shares you may apply for. 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. You, as the applicant(s), must complete the form in English (in Block Letters) as indicated below and sign on the second page of the Application Form. Only written signatures will be accepted (and not by way of personal chop). If you are applying through a designated CCASS Participant (other than a CCASS Investor Participant): ‧the designated CCASS Participant must endorse the form with its company chop (bearing its company name) and insert its participant I.D. in the appropriate box. If you are applying as an individual CCASS Investor Participant: ‧the form must contain your NAME and Hong Kong I.D. Card number; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a joint individual CCASS Investor Participant: ‧the form must contain all joint investor participants’ NAMES and the Hong Kong I.D. Card number of all joint investor participants; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a corporate CCASS Investor Participant: ‧the form must contain your company NAME and Hong Kong Business Registration number; ‧your participant I.D. and your company chop (bearing your company name) must be inserted in the appropriate box. S mp e樣版	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected. NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS No. of Amount No. of Amount No. of Amount No. of Amount Hong Kong payable on Hong Kong payable on Hong Kong payable on Hong Kong payable on Offer Shares application Offer Shares application Offer Shares application Offer Shares application applied for HK$ applied for HK$ applied for HK$ applied for HK$ 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) Maximum number of Hong Kong Offer Shares you may apply for. 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. You, as the applicant(s), must complete the form in English (in Block Letters) as indicated below and sign on the second page of the Application Form. Only written signatures will be accepted (and not by way of personal chop). If you are applying through a designated CCASS Participant (other than a CCASS Investor Participant): ‧the designated CCASS Participant must endorse the form with its company chop (bearing its company name) and insert its participant I.D. in the appropriate box. If you are applying as an individual CCASS Investor Participant: ‧the form must contain your NAME and Hong Kong I.D. Card number; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a joint individual CCASS Investor Participant: ‧the form must contain all joint investor participants’ NAMES and the Hong Kong I.D. Card number of all joint investor participants; ‧your participant I.D. must be inserted in the appropriate box. If you are applying as a corporate CCASS Investor Participant: ‧the form must contain your company NAME and Hong Kong Business Registration number; ‧your participant I.D. and your company chop (bearing your company name) must be inserted in the appropriate box. S mp e樣版
		Incorrect or omission of details of the CCASS Participant including participant I.D. and/or company chop
		bearing its company name or other similar matters may render your application invalid.

Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements:

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited (“HKSCC Nominees”) and deposited directly into the Central Clearing and Settlement System (“CCASS”) for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

The cheque must: Banker’s cashier order must: • be in Hong Kong dollars; • not be post-dated; • be made payable to “ BANK OF CHINA (HONG KONG) NOMINEES LIMITED – MABPHARM PUBLIC OFFER ”; ” • be crossed “Account Payee Only ; • be drawn on your Hong Kong dollar bank • be issued by a licensed bank in Hong Kong, and account in Hong Kong; and have your name certified on the back by a person • show your account name, which must either be authorised by the bank. The name on the banker’s pre-printed on the cheque, or be endorsed on the cashier order must correspond with your name. back by a person authorised by the bank. This If it is a joint application, the name on the back account name must correspond with your name. of the banker’s cashier order must be the same as If it is a joint application, the account name must the first-named applicant’s name. be the same as the first-named applicant’s name. 4. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of the receiving banks: Bank of China (Hong Kong) Limited District Branch name Address Hong Kong Island Des Voeux Road West Branch 111-119 Des Voeux Road West, Hong Kong Central District (Wing On B/F-2/F, Wing On House, 71 Des Voeux Road Central, House) Branch Hong Kong Kowloon Whampoa Garden Branch Shop G8B, Site 1, Whampoa Garden, Hung Hom, Kowloon Jordan Road Branch 1/F, Sino Cheer Plaza, 23-29 Jordan Road, Kowloon New Territories Tai Po Branch 68-70 Po Heung Street, Tai Po Market, New Territories Yuen Long (Hang Fat 8-18 Castle Peak Road, Yuen Long, New Territories Mansion) Branch CMB Wing Lung Bank Limited District Branch name Address Hong Kong Island Head Office 45 Des Voeux Road Central Kennedy Town Branch 28 Catchick Street Aberdeen Branch 201 Aberdeen Main Road Kowloon Mongkok Branch B/F Wing Lung Bank Centre, 636 Nathan Road San Po Kong Branch 8 Shung Ling Street 5. Your Application Form can be lodged at these times: — Monday, May 20, 2019 9:00 a.m. to 5:00 p.m. Tuesday, May 21, 2019 — 9:00 a.m. to 5:00 p.m. — Wednesday, May 22, 2019 9:00 a.m. to 5:00 p.m. — Thursday, May 23, 2019 9:00 a.m. to 5:00 p.m Friday, May 24, 2019 — 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Friday, May 24, 2019. The application lists will be open between 11:45 a.m. and 12:00 noon on that day, subject only to the weather conditions, as described in the section headed “How to Apply for Hong Kong Offer Shares – 10. Effect of Bad Weather on the Opening of the Application Lists” in the Prospectus.

如閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售股份，並直接存入中央結算及交收系統（「中央結算系統」），以寄存於閣下的中央結算系統投資者戶口持有人股份戶口或閣下指定的中央結算系統參與者股份戶口，請使用本表格

申請手續

1. 請使用下表計算閣下應付的款項。閣下申請認購的股數須至少為2,000股香港發售股份，並為下表所列的其中一個數目，否則閣下的申請將不獲受理。可供申請認購股份數目及應繳款項申請認購的申請時申請認購的申請時申請認購的申請時申請認購的申請時香港發售股份數目應繳款項港元香港發售股份數目應繳款項港元香港發售股份數目應繳款項港元香港發售股份數目應繳款項港元 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) 閣下可申請認購的香港發售股份最高數目。 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. 閣下作為申請人，必須按照下列指示以英文（正楷）填妥表格，並於申請表格次頁簽署。僅接納親筆簽名（不得以個人印鑑代替）。如閣下透過中央結算系統投資者戶口持有人以外的指定中央結算系統參與者提出申請： ‧ 該指定中央結算系統參與者須於表格加蓋公司印鑑（附有公司名稱），並在適當方格內填寫參與者編號。如閣下以個人中央結算系統投資者戶口持有人名義提出申請： ‧ 表格須載有閣下的姓名及香港身份證號碼； ‧ 須在適當方格內填寫閣下的參與者編號。如閣下以聯名個人中央結算系統投資者戶口持有人名義提出申請： ‧ 表格須載有所有聯名投資者戶口持有人的姓名及香港身份證號碼； ‧ 須在適當方格內填寫閣下的參與者編號。如閣下以公司中央結算系統投資者戶口持有人名義提出申請： ‧ 表格須載有閣下的公司名稱及香港商業登記號碼； ‧ 須在適當方格內填寫閣下的參與者編號並加蓋公司印鑑（附有公司名稱）。中央結算系統參與者的資料（包括參與者編號及╱或顯示公司名稱的公司印鑑）或其他類似事項 Sample樣版	1. 請使用下表計算閣下應付的款項。閣下申請認購的股數須至少為2,000股香港發售股份，並為下表所列的其中一個數目，否則閣下的申請將不獲受理。可供申請認購股份數目及應繳款項申請認購的申請時申請認購的申請時申請認購的申請時申請認購的申請時香港發售股份數目應繳款項港元香港發售股份數目應繳款項港元香港發售股份數目應繳款項港元香港發售股份數目應繳款項港元 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) 閣下可申請認購的香港發售股份最高數目。 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. 閣下作為申請人，必須按照下列指示以英文（正楷）填妥表格，並於申請表格次頁簽署。僅接納親筆簽名（不得以個人印鑑代替）。如閣下透過中央結算系統投資者戶口持有人以外的指定中央結算系統參與者提出申請： ‧ 該指定中央結算系統參與者須於表格加蓋公司印鑑（附有公司名稱），並在適當方格內填寫參與者編號。如閣下以個人中央結算系統投資者戶口持有人名義提出申請： ‧ 表格須載有閣下的姓名及香港身份證號碼； ‧ 須在適當方格內填寫閣下的參與者編號。如閣下以聯名個人中央結算系統投資者戶口持有人名義提出申請： ‧ 表格須載有所有聯名投資者戶口持有人的姓名及香港身份證號碼； ‧ 須在適當方格內填寫閣下的參與者編號。如閣下以公司中央結算系統投資者戶口持有人名義提出申請： ‧ 表格須載有閣下的公司名稱及香港商業登記號碼； ‧ 須在適當方格內填寫閣下的參與者編號並加蓋公司印鑑（附有公司名稱）。中央結算系統參與者的資料（包括參與者編號及╱或顯示公司名稱的公司印鑑）或其他類似事項 Sample樣版
如有錯漏，均可能導致申請無效。

1.
請使用下表計算閣下應付的款項。閣下申請認購的股數須至少為2,000股香港發售股份，並
為下表所列的其中一個數目，否則閣下的申請將不獲受理。
可供申請認購股份數目及應繳款項
申請認購的
申請時
申請認購的
申請時
申請認購的
申請時
申請認購的
申請時
香港發售
股份數目
應繳款項
港元
香港發售
股份數目
應繳款項
港元
香港發售
股份數目
應繳款項
港元
香港發售
股份數目
應繳款項
港元
2,000
3,939.31
60,000
118,179.01
600,000
1,181,790.09
6,000,000
11,817,900.90
4,000
7,878.60
70,000
137,875.52
700,000
1,378,755.11
7,000,000
13,787,551.05
6,000
11,817.91
80,000
157,572.01
800,000
1,575,720.12
8,000,000
15,757,201.20
8,000
15,757.20
90,000
177,268.52
900,000
1,772,685.14
9,000,000
17,726,851.35
10,000
19,696.51
100,000
196,965.02
1,000,000
1,969,650.15
10,000,000
19,696,501.50
12,000
23,635.80
150,000
295,447.53
1,500,000
2,954,475.23
15,000,000
29,544,752.25
14,000
27,575.11
200,000
393,930.03
2,000,000
3,939,300.30
20,000,000
39,393,003.00
16,000
31,514.40
250,000
492,412.54
2,500,000
4,924,125.38
25,000,000
49,241,253.75
18,000
35,453.71
300,000
590,895.05
3,000,000
5,908,950.45
30,000,000
59,089,504.50
20,000
39,393.00
350,000
689,377.56
3,500,000
6,893,775.53
35,000,000
68,937,755.25
30,000
59,089.51
400,000
787,860.06
4,000,000
7,878,600.60
39,178,000(1)
77,166,953.58
40,000
78,786.01
450,000
886,342.57
4,500,000
8,863,425.68
(1)
閣下可申請認購的香港發
售股份最高數目。
50,000
98,482.51
500,000
984,825.08
5,000,000
9,848,250.75
2.
閣下作為申請人，必須按照下列指示以英文（正楷）填妥表格，並於申請表格次頁簽署。僅接納
親筆簽名（不得以個人印鑑代替）。
如閣下透過中央結算系統投資者戶口持有人以外的指定中央結算系統參與者提出申請：
‧ 該指定中央結算系統參與者須於表格加蓋公司印鑑（附有公司名稱），並在適當方格內填寫參
與者編號。
如閣下以個人中央結算系統投資者戶口持有人名義提出申請：
‧ 表格須載有閣下的姓名及香港身份證號碼；
‧ 須在適當方格內填寫閣下的參與者編號。
如閣下以聯名個人中央結算系統投資者戶口持有人名義提出申請：
‧ 表格須載有所有聯名投資者戶口持有人的姓名及香港身份證號碼；
‧ 須在適當方格內填寫閣下的參與者編號。
如閣下以公司中央結算系統投資者戶口持有人名義提出申請：
‧ 表格須載有閣下的公司名稱及香港商業登記號碼；
‧ 須在適當方格內填寫閣下的參與者編號並加蓋公司印鑑（附有公司名稱）。
中央結算系統參與者的資料（包括參與者編號及╱或顯示公司名稱的公司印鑑）或其他類似事項
Sample樣版

如有錯漏，均可能導致申請無效。

閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須隨附一張獨立開出支票或一張獨立開出銀行本票。支票或銀行本票必須符合以下所有規定，否則閣下的申請將不獲受理：

支票須：銀行本票須： ‧ 為港元； ‧ 不得為期票； ‧ 註明抬頭人為「 中國銀行（香港）代理人有限公司－邁博藥業公開發售 」； ‧ 劃線註明「只准入抬頭人賬戶」； ‧ ‧ 從閣下在香港的港元銀行賬戶中開出；及由香港持牌銀行開出，並由有關銀行授權的 ‧ 顯示閣下的賬戶名稱，而該賬戶名稱須已人士在銀行本票背面簽署核證閣下的姓名預印在支票上，或由有關銀行授權的人士在 ╱名稱。銀行本票所示姓名╱名稱須與閣支票背書。該賬戶名稱須與閣下的姓名╱ 下的姓名╱名稱相同。如屬聯名申請，則銀名稱相同。如屬聯名申請，則賬戶名稱須與行本票背面所示姓名╱名稱須與排名首位申排名首位申請人的姓名╱名稱相同。請人的姓名╱名稱相同。 4. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同支票或銀行本票）投入收款銀行的下列任何一家分行的收集箱： 中國銀行（香港）有限公司地區分行名稱地址香港島 德輔道西分行香港德輔道西 111-119 號中環永安集團大廈分行香港德輔道中 71 號永安集團大廈地庫至二樓九龍黃埔花園分行九龍紅磡黃埔花園第一期商場 G8B 號佐敦道分行九龍佐敦道 23-29 號新寶廣場一樓新界大埔分行新界大埔墟寶鄉街 68-70 號元朗恒發樓分行新界元朗青山公路 8-18 號 招商永隆銀行有限公司地區分行名稱地址香港島 總行德輔道中 45 號堅尼地城分行吉席街 28 號香港仔分行香港仔大道 201 號九龍旺角分行彌敦道 636 號招商永隆銀行中心地庫新蒲崗分行崇齡街 8 號 5. 閣下可於下列時間遞交申請表格： 2019 年 5 月 20 日（星期一）－上午九時正至下午五時正 2019 年 5 月 21 日（星期二）－上午九時正至下午五時正 2019 年 5 月 22 日（星期三）－上午九時正至下午五時正 2019 年 5 月 23 日（星期四）－上午九時正至下午五時正 2019 年 5 月 24 日（星期五）－上午九時正至中午十二時正 6. 截止遞交申請的時間為 2019 年 5 月 24 日（星期五）中午十二時正。開始登記申請的時間為當日上午十一時四十五分至中午十二時正，唯一會影響此時間的變化因素為當日的天氣情況（詳見招股章程「如何申請香港發售股份－10. 惡劣天氣對開始辦理申請登記的影響」一節）。

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited (“HKSCC Nominees”) and deposited directly into the Central Clearing and Settlement System (“CCASS”) for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant Mabpharm Limited 邁博藥業有限公司 (Incorporated in the Cayman Islands with limited liability) GLOBAL OFFERING Conditions of your application ‧ confirm that you are aware of the restrictions on the Global Offering in the prospectus; A. Who can apply ‧ agree that none of the Company, the Sole Global Coordinator, 1. You and any person(s) for whose benefit you are applying must be the Sole Sponsor, the Sole Bookrunner, the Underwriters, their 18 years of age or older and must have a Hong Kong address. 2. If you are a firm, the application must be in the individual respective directors, officers, employees, partners, agents, advisers members’ names. and any other parties involved in the Global Offering is or will be 3. The number of joint applicants may not exceed 4. liable for any information and representations not in the Prospectus 4. If you are a body corporate, the application must be signed by a (and any supplement to it); duly authorised officer, who must state his representative capacity, ‧ undertake and confirm that you or the person(s) for whose and stamped with your corporation’s chop. benefit you have made the application have not applied for 5. You must be outside the United States, not be a United States or taken up, or indicated an interest for, and will not apply Person (as defined in Regulation S under the U.S. Securities Act) for or take up, or indicate an interest for, any Offer Shares and not be a legal or natural person of the PRC. under the International Offering nor participated in the 6. Unless permitted by the Listing Rules, you cannot apply for any International Offering; Hong Kong Offer Shares if you: ‧ agree to disclose to the Company, the Hong Kong Share Registrar, ‧ are an existing beneficial owner of Shares in the Company the receiving banks, the Sole Global Coordinator, Sole Sponsor, the and/or any of its subsidiaries; Sole Bookrunner, the Underwriters and/or their respective advisers ‧ are a Director or chief executive officer of the Company and/ and agents any personal data which they may require about you and ‧ or any of its subsidiaries; th e person(s) for whose benefit you have made the application; are a connected person (as defined in the Listing Rules) ‧ if the laws of any place outside Hong Kong apply to your of the Company or will become a connected person of application, agree and warrant that you have complied with all the Company immediately upon completion of the Global such laws and none of the Company, the Sole Global Coordinator, Offering; ‧ are an associate (as defined in the Listing Rules) of any of the Sole Sponsor, the Sole Bookrunner and the Underwriters nor any of their respective officers or advisers will breach any law the above; or ‧ outside Hong Kong as a result of the acceptance of your offer to have been allocated or have applied for or indicated an interest in any International Offer Shares or otherwise purchase, or any action arising from your rights and obligations participate in the International Offering. under the terms and conditions contained in the Prospectus and this Application Form; B. If you are a nominee ‧ agree that once your application has been accepted, you may not You, as a nominee, may make more than one application for the Hong rescind it because of an innocent misrepresentation; Kong Offer Shares by: (i) giving electronic instructions to HKSCC via ‧ agree that your application will be governed by the laws of Hong Central Clearing and Settlement System (“CCASS”) (if you are a CCASS Kong; Participant); or (ii) using a WHITE or YELLOW Application Form, and ‧ represent, warrant and undertake that (i) you understand that the lodge more than one application in your own na m e on behalf of different Hong Kong Offer Shares have not been and will not be registered beneficial owners. under the U.S. Securities Act; and (ii) you and any person for C. Effect of completing and submitting this Application Form whose benefit you are applying for the Hong Kong Offer Shares By completing and submitting this Application Form, you (and if you are are outside the United States (as defined in Regulation S) or are a joint applicants, each of you jointly and severally) for yourself or as an person described in paragraph (h) (3) of Rule 902 of Regulation S; agent or a nominee on behalf of e a ch person for whom you act: ‧ warrant that the information you have provided is true and accurate; ‧ undertake to execute all relevant documents and instruct and ‧ agree to accept the Hong Kong Offer Shares applied for, or any authorise the Company and/or the Sole Global Coordinator (or their lesser number allocated to you under the application; agents or nominees), as agents of the Company, to execute any ‧ authorise (i) the Company to place the name of the HKSCC documents for you and to do on your behalf all things necessary to Nominees on the Company’s register of members as the holder(s) register any Hong Kong Offer Shares allocated to you in the name of any Hong Kong Offer Shares allocated to you and such other of HKSCC Nominees as required by the Articles; ‧ agree to comply with the Cayman Islands Law, Companies registers as required under the Memorandum and Articles of Association of the Company and (ii) the Company and/or its agents Ordinance, the Companies (Winding Up and Miscellaneous to deposit any share certificate(s) into CCASS and/or to send Provisions) Ordinance and the Memorandum and Articles of the any refund cheque(s) to you or the first-named applicant for joint Company;

‧ authorise (i) the Company to place the name of the HKSCC Nominees on the Company’s register of members as the holder(s) of any Hong Kong Offer Shares allocated to you and such other registers as required under the Memorandum and Articles of Association of the Company and (ii) the Company and/or its agents to deposit any share certificate(s) into CCASS and/or to send any refund cheque(s) to you or the first-named applicant for joint application by ordinary post at your own risk to the address stated on the application, unless you have fulfilled the criteria mentioned in “Personal Collection” section in the Prospectus to collect refund cheque(s) in person;
‧ confirm that you have read the terms and conditions and application procedures set out in the Prospectus and in this Application Form and agree to be bound by them;
‧ confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;
‧ agree that the Hong Kong Offer Shares to be allotted shall be issued in the name of HKSCC Nominees and deposited directly into CCASS for credit to your investor participant stock account or the stock account of your designated CCASS Participant;

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited (“HKSCC Nominees”) and deposited directly into the Central Clearing and Settlement System (“CCASS”) for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

‧ agree that each of HKSCC and HKSCC Nominees reserves the If the Company decides to set the Offer Price after making a Downward right (1) not to accept any or part of such allotted shares issued in Offer Price Adjustment (a reduction of up to 10% below HK$1.50), the the name of HKSCC Nominees or not to accept such allotted shares Company will separately announce the final Offer Price no later than for deposit into CCASS; (2) to cause such allotted shares to be Thursday, May 30, 2019 on the website of the Stock Exchange at www. withdrawn from CCASS and issued in your name at your own risk hkexnews.hk and the Company’s website at www.mabpharm.cn . and costs; and (3) to cause such allotted shares to be issued in your Irrespective of whether a Downward Offer Price Adjustment is made, name (or, if you are a joint applicant, to the first-named applicant) Company expects to announce the final Offer Price, the indication of the and in such a case, to post the certificates for such allotted shares at level of interest in the International Offering, the level of applications your own risk to the address on your application form by ordinary under the Hong Kong Public Offering and the basis of allocation of the post or to make available the same for your collection; ‧ agree that each of HKSCC and HKSCC Nominees may adjust the Hong Kong Offer Shares on Thursday, May 30, 2019 in South China Morning Post (in English) and the Hong Kong Economic Times (in number of allotted shares issued in the name of HKSCC Nominees; ‧ agree that neither HKSCC nor HKSCC Nominees shall have any Chinese), the website of the Stock Exchange at www.hkexnews.hk and the Company’s website at www.mabpharm.cn . Results of allocations and liability for the information and representations not so contained in the Hong Kong identity card/passport/Hong Kong business registration the Prospectus and this Application Form; ‧ agree that neither HKSCC nor HKSCC Nominees shall be liable to numbers of successful applicants (where applicable) under the Hong Kong Public Offering will be available at the times and dates and in the manner you in any way; ‧ understand that, in accordance with Guidance Letter HKExGL91-18 described in the section headed “How to Apply for Hong Kong Offer Shares – 11. Publication of Results” in the Prospectus. issued by the Stock Exchange where the International Offer Shares are undersubscribed and the Hong Kong Offer Shares If your application for Hong Kong Offer Shares is successful (in are oversubscribed irrespective of the number of times, up to whole or in part) 78,358,000 Shares may be reallocated to the Hong Kong Public If your application is wholly or partially successful, your share Offering from the International Offering, so that the total number certificate(s) (subject to their becoming valid certificates of title provided of the Shares available under the Hong Kong Public Offer will that the Hong Kong Public Offering has become unconditional and not be increased to 156,716,000 Shares, representing 20% of the having been terminated at 8:00 a.m. on Friday, May 31, 2019) will be number of the Offer Shares initially available under the Global issued in the name of HKSCC Nominees and deposited directly into Offering (before any exercise of the Over-allotment Option), and CCASS for credit to your CCASS Investor Participant stock account or the final Offer Price shall be fixed at the low-end of the indicative the stock account of your designated CCASS Participant as instructed by Offer Price range (i.e. HK$1.50 per Offer Share) as stated in the you in your Application Form on Thursday, May 30, 2019 or, in the event Prospectus. Further details of the reallocation are stated in the of a contingency, on any other date as shall be determined by HKSCC or paragraph headed “Structure of the Global Offering — Reallocation HKSCC Nominees. and clawback” of the Prospectus; ‧ If you are applying through a designated CCASS Participant (other ‧ declare and represent that this is the only application made and the than a CCASS Investor Participant): For Hong Kong Offer Shares only application intended by you to be made to benefit you or the credited to the stock account of your designated CCASS Participant person for whose benefit you are applying; (oth e r than a CCASS Investor Participant), you can check the ‧ understand that the Company and the Sole Global Coordinator number of Hong Kong Offer Shares allotted to you with that willrely on your declarat ions and representations in deciding CCASS Participant. whether or not to make any allotment of any of the Hong Kong ‧ If you are applying as a CCASS Investor Participant: The Company Offer Shares to you and that you may be prosecuted for making a expects to publish the results of CCASS Investor Participants’ false declaration; ‧ (if the application is made for your own benefit) warrant that no applications together with the results of the Hong Kong Public Offering in the manner described in the section headed “How to other application has been or will be made for your benefit on a WHITE or YELLOW Application Form or by giving electronic Apply for Hong Kong Offer Shares – 11. Publication of Results” application instructions to HKSCC or to the White Form eIPO in the Prospectus on Thursday, May 30, 2019. You should check the announcement published by the Company and report any Service Provider by you or by any one as your agent or by any discrepancies to HKSCC before 5:00 p.m. on Thursday, May 30, other person; and ‧ (if you are making the application as an agent for the benefit of 2019 or such other date as shall be determined by HKSCC or HKSCC Nominees. Immediately after the credit of the Hong Kong another person) warrant that (i) no other application has been or Offer Shares to your stock account you can check your new account will be made by you as agent for or for the benefit of that person balance via the CCASS Phone System and CCASS Internet System or by that person or by any other person as agent for that person on a WHITE or YELLOW Application Form or by giving (under the procedures contained in HKSCC’s “An Operating Guide for Investor Participants” in effect from time to time). HKSCC electronic application instructions to HKSCC; and (ii) you have due authority to sign the Application Form or give electronic will also make available to you an activity statement showing the number of Hong Kong Offer Shares credited to your stock account. application instructions on behalf of that other person as their agent. No receipt will be issued for application money paid. The Company will not issue temporary documents of title. D. Power of attorney If your application is made through an authorised attorney, the Company Refund of your money and the Sole Global Coordinator may accept or reject your application at If an application is rejected, not accepted or accepted in part only, or if the its discretion, and on any conditions it thinks fit, including evidence of the Offer Price as finally determined is less than the maximum Offer Price of attorney’s authority. HK$1.95 per Offer Share (excluding brokerage, SFC transaction levy and the Stock Exchange trading fee thereon), or if the conditions of the Hong Determination of Offer Price and Allocation of Hong Kong Offer Kong Public Offering are not fulfilled in accordance with “Structure of the Shares Global Offering – Conditions of the Global Offering” in the Prospectus The Offer Price is expected to be fixed on or around Friday, May 24, or if any application is revoked, the application monies, or the appropriate 2019. Applicants are required to pay the maximum Offer Price of portion thereof, together with the related brokerage, SFC transaction levy HK$1.95 for each Offer Share together with brokerage fee of 1%, SFC and the Stock Exchange trading fee, will be refunded, without interest or transaction levy of 0.0027% and Stock Exchange trading fee of 0.005%. the cheque or banker’s cashier order will not be cleared.

‧ (if you are making the application as an agent for the benefit of another person) warrant that (i) no other application has been or will be made by you as agent for or for the benefit of that person or by that person or by any other person as agent for that person on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC; and (ii) you have due authority to sign the Application Form or give electronic application instructions on behalf of that other person as their agent.

D. Power of attorney

If your application is made through an authorised attorney, the Company and the Sole Global Coordinator may accept or reject your application at its discretion, and on any conditions it thinks fit, including evidence of the attorney’s authority.

The Offer Price is expected to be fixed on or around Friday, May 24, 2019. Applicants are required to pay the maximum Offer Price of HK$1.95 for each Offer Share together with brokerage fee of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005%. If the Offer Price is not agreed between the Company and the Sole Global Coordinator (for itself and on behalf of the Underwriters) on or before Sunday, May 26, 2019, the Global Offering will not proceed.

Any refund of the application monies will be made on Thursday, May 30, 2019.

The refund procedures are stated in the section headed “How to Apply for Hong Kong Offer Shares – 14. Despatch/Collection of Share Certificates and Refund Monies” in the Prospectus.

Applications for Hong Kong Offer Shares will not be processed and no allotment of any Hong Kong Offer Shares will be made until the application lists close.

如閣下欲以香港中央結算（代理人）有限公司（「香港結算代理人」）的名義登記將獲發行的香港發售股份，並直接存入中央結算及交收系統（「中央結算系統」），以寄存於閣下的中央結算系統投資者戶口持有人股份戶口或閣下指定的中央結算系統參與者股份戶口，請使用本表格 Mabpharm Limited 邁博藥業有限公司（於開曼群島註冊成立的有限公司） 全球發售申請條件 ‧ 同意本公司、獨家全球協調人、獨家保薦人、獨家賬簿管理人、包銷商、彼等各自的董事、高級職員、僱 甲 . 可提出申請的人士 員、合夥人、代理、顧問及參與全球發售的任何其他 1. 閣下及閣下為其利益提出申請的任何人士必須年滿各方目前或將來均毋須對並非載於招股章程（及其任 18 歲並有香港地址。何補充文件）的任何資料及陳述負責； 2. 如閣下為商號，申請須以個別成員名義提出。 ‧ 承諾及確認閣下或閣下為其利益提出申請的人士 3. 聯名申請人不得超過四名。並無申請或接納或表示有意認購（且將不會申請或接 4. 如閣下為法人團體，申請須經獲正式授權人員簽納或表示有意認購）國際發售項下的任何發售股份，署，並註明其所代表身份及加蓋閣下的公司印鑑。亦無參與國際發售； 5. 閣下必須身處美國境外，並非美籍人士（定義見美國 ‧ 同意向本公司、香港證券登記處、收款銀行、獨家全證券法 S 規例），亦非中國法人或自然人。球協調人、獨家保薦人、獨家賬簿管理人、包銷商及 6. 除上市規則批准外，下列人士概不得申請認購任何香 ╱或彼等各自的顧問及代理披露彼等所要求有關閣港發售股份： ‧ 下及閣下為其利益提出申請的人士的任何個人資本公司及╱或其任何附屬公司股份的現有實益擁料；有人； ‧ ‧ 若香港境外任何地方的法律適用於閣下的申請，則本公司及╱或其任何附屬公司的董事或行政總同意及保證閣下已遵守所有有關法律，且本公司、裁； ‧ 本公司關連人士（定義見上市規則）或緊隨全球發獨家全球協調人、獨家保薦人、獨家賬簿管理人及包銷商以及彼等各自的任何高級職員或顧問概不會因接售完成後將成為本公司關連人士的人士； ‧ 上述任何人士的聯繫人（定義見上市規則）；或納閣下的購買要約，或閣下在招股章程及本申請 ‧ 表格所載條款及條件下的權利及責任所引致的任何行已獲分配或已申請或表示有意申請任何國際發售動，而違反香港境外的任何法律；股份或以其他方式參與國際發售的人士。 ‧ 同意閣下的申請一經接納，概不得因無意的失實陳 乙 . 如閣下為代名人 述而撤回；閣下作為代名人可提交超過一份香港發售股份申請，方法 ‧ 同意閣下的申請將受香港法例規管；是：(i) 透過中央結算及交收系統（「中央結算系統」）向香港 ‧ 聲明、保證及承諾：(i) 閣下明白香港發售股份不曾結算發出電子指示（如閣下為中央結算系統參與者）；或亦不會根據美國證券法登記；及 (ii) 閣下及閣下 (ii) 使用白色或黃色申請表格，以自身名義代表不同的實益為其利益申請香港發售股份的任何人士均身處美國境擁有人提交超過一份申請。外（定義見 S 規例），或均屬 S 規例第 902 條第 (h)(3) 丙 . 填交本申請表格的效用 段所述人士；閣下填妥並遞交本申請表格，即表示閣下（如屬聯名申請 ‧ 保證閣下提供的資料真實及準確；人，即各人共同及個別）代表閣下本身，或作為閣下代 ‧ 同意接納所申請數目或分配予閣下但數目少於申請其行事的每位人士的代理或代名人：數目的香港發售股份； ‧ 承諾簽署所有相關文件，並指示及授權本公司及╱或 ‧ 授權 (i) 本公司將香港結算代理人的名稱列入本公司獨家全球協調人（或彼等的代理或代名人）作為本公股東名冊及本公司組織章程大綱及細則規定的其他司的代理，按細則的規定代閣下簽署任何文件並代名冊，作為閣下獲分配的任何香港發售股份的持表閣下處理一切必要事宜，以將閣下獲配發的任有人，及 (ii) 本公司及╱或其代理將任何股票存入中何香港發售股份以香港結算代理人的名義登記；央結算系統及╱或以普通郵遞方式按申請所示地址 ‧ 同意遵守開曼群島法律、公司條例、公司（清盤及雜向閣下或聯名申請的排名首位申請人寄發任何退款項條文）條例及本公司大綱及細則；支票，郵誤風險由閣下承擔，惟閣下符合招股章 ‧ 確認閣下已細閱招股章程及本申請表格所載的條款程「親身領取」一節所述標準親身領取退款支票則除外；

‧ 確認閣下已細閱招股章程及本申請表格所載的條款及條件以及申請程序，並同意受其約束；
‧ 同意將獲配發的香港發售股份以香港結算代理人的名義發行，並直接存入中央結算系統，以寄存於閣下的投資者戶口持有人股份戶口或閣下指定的中央結算系統參與者股份戶口；
‧ 確認閣下已接獲並細閱招股章程，且提出申請時僅依賴招股章程所載資料及陳述，而不會依賴任何其他資料或陳述（招股章程任何補充文件所載者除外）；
‧ 確認閣下知悉招股章程內有關全球發售的限制；

‧ 同意香港結算及香港結算代理人各自保留權利 (1) 不倘本公司決定於下調發售價後釐定發售價（最多下調至 1.50 接納以香港結算代理人名義發行的該等獲配發的任何港元以下 10%），則本公司將在不遲於 2019 年 5 月 30 日（星或部分股份，或不接納該等獲配發的股份存入中央結期四）於聯交所網站 www.hkexnews.hk 及本公司網站 www. 算系統；(2) 促使該等獲配發的股份從中央結算系統 mabpharm.cn 上另行公佈最終發售價。提取，並以閣下的名義發行，有關風險及成本概不論是否下調發售價，本公司預期於 2019 年 5 月 30 日由閣下承擔；及 (3) 促使該等獲配發的股份以閣（星期四）在《南華早報》（以英文）及《香港經濟日報》（以中下的名義發行（或如屬聯名申請人，則以排名首位申文）、聯交所網站 www.hkexnews.hk 及本公司網站 www. 請人的名義發行），而在此情況下，會以普通郵遞方 mabpharm.cn 公佈最終發售價、國際發售踴躍程度、香港式將該等獲配發股份的股票寄往閣下的申請表格所公開發售申請水平及香港發售股份分配基準。香港公開發示地址（郵誤風險概由閣下承擔）或提供該等股票售的分配結果以及根據香港公開發售成功申請人的香港身予閣下領取；份證號碼╱護照號碼╱香港商業登記號碼（如適用）亦同於 ‧ 同意香港結算及香港結算代理人均可調整以香港結算招股章程「如何申請香港發售股份－11. 公佈結果」一節所述代理人名義發行的獲配發股份數目；時間、日期及方式公佈。 ‧ 同意香港結算及香港結算代理人對招股章程及本申請 如閣下成功申請認購香港發售股份（全部或部分） 表格未有載列的資料及陳述概不負責；如閣下的申請全部或部分獲接納，則閣下的股票（前提 ‧ 同意香港結算及香港結算代理人概不以任何方式對閣是到 2019 年 5 月 31 日（星期五）上午八時正香港公開發售成下負責；為無條件且並無終止，股票方會成為有效的所有權憑證）將 ‧ 明白根據聯交所發佈的指引函 HKExGL91-18，倘國以香港結算代理人的名義發出，並按閣下在申請表格的際發售股份認購不足而香港發售股份獲超額認購（不指示於 2019 年 5 月 30 日（星期四）或在特別情況下由香港結論倍數如何），最多 78,358,000 股發售股份可自國際算或香港結算代理人釐定的任何其他日期直接存入中央結發售重新分配至香港公開發售，故香港公開發售可供算系統，以寄存於閣下的中央結算系統投資者戶口持有認購的股份總數將增至 156,716,000 股股份，相當於人股份戶口或閣下指定的中央結算系統參與者股份戶口。全球發售初步可供認購發售股份數目的 20%（超額配 ‧ 如閣下透過中央結算系統投資者戶口持有人以外的股權獲行使前），而最終發售價須定為招股章程所述指定中央結算系統參與者提出申請：就寄存於閣下指標發售價範圍的下限（即每股發售股份 1.50 港元）。指定的中央結算系統參與者（非中央結算系統投資者重新分配的詳情載於招股章程「全球發售架構－重新戶口持有人）股份戶口的香港發售股份而言，閣下可分配及回撥」一段；向該中央結算系統參與者查詢閣下獲配發的香港發 ‧ 聲明及表示此乃閣下為本身或閣下為其利益提出售股份數目。申請的人士所提出及擬提出的唯一申請； ‧ 如閣下以中央結算系統投資者戶口持有人身份提出 ‧ 明白本公司及獨家全球協調人將依賴閣下的聲明申請：本公司預期於 2019 年 5 月 30 日（星期四）按招及陳述而決定是否向閣下配發任何香港發售股股章程「如何申請香港發售股份－11. 公佈結果」一節份，閣下如作出虛假聲明，可能會被檢控；所述方式刊登中央結算系統投資者戶口持有人的申請 ‧ （倘申請為閣下本身的利益提出）保證閣下或作結果及香港公開發售的結果。閣下應查閱本公司刊為閣下代理的任何人士或任何其他人士不曾亦不會發的公告，如有任何資料不符，請於 2019 年 5 月 30 日為閣下的利益以白色或黃色申請表格或向香港結算（星期四）或香港結算或香港結算代理人釐定的其他日或 白表 eIPO 服務供應商發出 電子認購指示 而提出其期下午五時正前知會香港結算。緊隨香港發售股份存他申請；及入閣下的股份戶口後，閣下即可透過「結算通」電 ‧ （倘閣下作為代理為另一人士的利益提出申請）保證話系統及中央結算系統互聯網系統（根據香港結算不時生效的「投資者戶口操作簡介」所載程序）查詢閣 (i) 閣下（作為代理或為該人士利益）或該人士或任何下的新戶口結餘。香港結算亦將向閣下提供一份活其他作為該人士代理的人士不曾亦不會以白色或黃色動結單，列出存入閣下股份戶口的香港發售股份數申請表格或向香港結算發出 電子認購指示 提出其他申目。請；及 (ii) 閣下獲正式授權作為該其他人士的代理。本公司不會就申請時繳付的款項發出收據，亦不會發出臨代為簽署本申請表格或發出 電子認購指示 時所有權文件。 丁 . 授權書退回款項 如閣下透過授權人士提出申請，本公司及獨家全球協調倘申請遭拒絕、不獲接納或僅部分獲接納，或最終釐定的人可按其認為合適的任何條件（包括出示獲授權人士的授權發售價低於最高發售價每股發售股份 1.95 港元（不包括有證明）酌情接納或拒絕閣下的申請。關的經紀佣金、證監會交易徵費及聯交所交易費），或香港 釐定發售價及分配香港發售股份 公開發售的條件並無按照招股章程「全球發售的架構－全球預期發售價將於 2019 年年 5 月月 24 日（星期五）或前後釐定。申日（星期五）或前後釐定。申發售的條件」一節所述者達成，又或任何申請遭撤回，申請請人須繳付每股發售股份 1.95 港元的最高發售價，另加港元的最高發售價，另加 1% 股款或其中適當部分連同相關經紀佣金、證監會交易徵費經紀佣金、0.0027% 證監會交易徵費及0.0027% 證監會交易徵費及證監會交易徵費及 0.005% 聯交所交易聯交所交易及聯交所交易費將不計利息退回或不將有關支票或銀行本費。倘本公司及獨家全球協調人（為其本身及代表包銷商）票過戶。

預期發售價將於 2019 年年 5 月月 24 日（星期五）或前後釐定。申日（星期五）或前後釐定。申請人須繳付每股發售股份 1.95 港元的最高發售價，另加港元的最高發售價，另加 1% 經紀佣金、0.0027% 證監會交易徵費及0.0027% 證監會交易徵費及證監會交易徵費及 0.005% 聯交所交易聯交所交易費。倘本公司及獨家全球協調人（為其本身及代表包銷商）並無於 2019 年 5 月 26 日（星期日）或之前協定發售價，則全球發售將不會進行。

任何退回申請股款將於 2019 年 5 月 30 日（星期四）作出。

截止登記申請前概不處理香港發售股份的申請或配發任何香港發售股份。

有關退款程序載於招股章程「如何申請香港發售股份－ 14. 發送╱領取股票及退回股款」一節。

Please use this form if you want the Hong Kong Offer Shares to be issued in the name of HKSCC Nominees Limited (“HKSCC Nominees”) and deposited directly into the Central Clearing and Settlement System (“CCASS”) for credit to your CCASS Investor Participant stock account or the stock account of your designated CCASS Participant

‧ any other incidental or associated purposes relating to the above and/or to enable the Company and the Hong Kong Share Registrar to discharge their obligations to securities’ holders and/or regulators and/or any other purposes to which the securities’ holders may from time to time agree.

Personal Data ‧ any other incidental or associated purposes relating to the above and/or to enable the Company and the Hong Personal Information Collection Statement Kong Share Registrar to discharge their obligations to This Personal Information Collection Statement informs the securities’ holders and/or regulators and/or any other applicant for, and holder of, Hong Kong Offer Shares, of the purposes to which the securities’ holders may from policies and practices of the Company and its Hong Kong time to time agree. Share Registrar in relation to personal data and the Personal 3. Transfer of personal data Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Personal data held by the Company and its Hong Kong Kong) (the “Ordinance”). Share Registrar relating to the securities holders will be kept 1. Reasons for the collection of your personal data confidential but the Company and its Hong Kong Share It is necessary for applicants and registered holders of securities Registrar may, to the extent necessary for achieving any of the above purposes, disclose, obtain or transfer (whether to supply correct personal data to the Company or its agents and within or outside Hong Kong) the personal data to, from or the Hong Kong Share Registrar when applying for securities or with any of the following: transferring securities into or out of their names or in procuring ‧ the Company’s appointed agents such as financial the services of the Hong Kong Share Registrar. advisers, receiving bank and overseas principal share Failure to supply the requested data may result in your registrar; application for securities being rejected, or in delay or the ‧ where applicants for securities request a deposit into inability of the Company or its Hong Kong Share Registrar CCASS, HKSCC or HKSCC Nominees, who will use to effect transfers or otherwise render their services. It may the personal data for the purposes of operating CCASS; also prevent or delay registration or transfers of the Hong ‧ any agents, contractors or third-party service providers Kong Offer Shares which you have successfully applied who offer administrative, telecommunications, computer, payment or other services to the Company for and/or the despatch of share certificate(s) and/or refund or the Hong Kong Share Registrar in connection with cheque(s) to which you are entitled. their respective business operation; It is important that securities holders inform the Company ‧ th e Stock Exchange, the SFC and any other statutory and the Hong Kong Share Registrar immediately of any regulatory or governmental bodies or otherwise as inaccuracies in the personal data supplied. required by laws, rules or regulations; and ‧ any persons or institutions with which the securities’ 2. Purposes holders have or propose to have dealings, such as their The personal data of the securities holders may be used, bankers, solicitors, accountants or stockbrokers etc. held, processed, and/or stored (by whatever means) for the following purposes: 4. Retention of personal data ‧ processing your application and refund cheque, where The Company and its Hong Kong Share Registrar will keep the personal data of the applicants and holders of securities applicable, verification of compliance with the terms for as long as necessary to fulfil the purposes for which and application procedures set out in this Application the personal data were collected. Personal data which is no Form and the Prospectus and announcing results of longer required will be destroyed or dealt with in accordance allocation of the Hong Kong Offer Shares; with the Ordinance. ‧ compliance with applicable laws and regulations in Hong Kong and elsewhere; 5. Access to and correction of personal data ‧ registering new issues or transfers into or out of Securities holders have the right to ascertain whether the the names of securities’ holders including, where Company or the Hong Kong Share Registrar hold their applicable, HKSCC Nominees; personal data, to obtain a copy of that data, and to correct ‧ maintaining or updating the register of securities’ any data that is inaccurate. The Company and the Hong Kong Share Registrar have the right to charge a reasonable holders of the Company; ‧ fee for the processing of such requests. verifying securities holders’ identities; ‧ establishing benefit entitlements of securities’ holders All requests for access to data or correction of data should of the Company, such as dividends, rights issues, bonus be addressed to us, at our registered address disclosed in issues, etc.; the “Corporate Information” section of the Prospectus or as

‧ processing your application and refund cheque, where applicable, verification of compliance with the terms and application procedures set out in this Application Form and the Prospectus and announcing results of allocation of the Hong Kong Offer Shares;
‧ compliance with applicable laws and regulations in Hong Kong and elsewhere;
‧ registering new issues or transfers into or out of the names of securities’ holders including, where applicable, HKSCC Nominees;
‧ maintaining or updating the register of securities’ holders of the Company;
‧ verifying securities holders’ identities;

All requests for access to data or correction of data should be addressed to us, at our registered address disclosed in the “Corporate Information” section of the Prospectus or as notified from time to time, for the attention of the company secretary, or our Hong Kong Share Registrar for the attention of the privacy compliance officer.

‧ distributing communications from the Company and its subsidiaries;
‧ compiling statistical information and securities’ holders profiles;

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

‧ disclosing relevant information to facilitate claims on entitlements; and

‧ 與上述有關的任何其他附帶或相關目的及╱ 或使本公司及香港證券登記處能履行對證券

‧ 個人資料 與上述有關的任何其他附帶或相關目的及╱ 或使本公司及香港證券登記處能履行對證券 個人資料收集聲明 持有人及╱或監管機構承擔的責任及╱或證此項個人資料收集聲明是向香港發售股份的申請券持有人不時同意的任何其他目的。人及持有人說明有關本公司及其香港證券登記處有關個人資料及香港法例第 486 章個人資料（私 3. 轉交個人資料 本公司及其香港證券登記處所持有關證券持有人隱）條例（「條例」）方面的政策及常規。的個人資料將會保密，但本公司及其香港證券登 1. 收集閣下個人資料的原因 記處可在為達致上述任何目的之必要情況下，向證券申請人及登記持有人以本身名義申請證券或下列任何人士或機構披露、獲取或轉交（無論在香港境內或境外）有關個人資料：轉讓或受讓證券時或尋求香港證券登記處的服務 ‧ 本公司委任的代理，例如財務顧問、收款銀時，必須向本公司或其代理及香港證券登記處提行及海外主要證券登記處；供準確的個人資料。 ‧ （倘證券申請人要求將證券存入中央結算系未能提供所要求的資料可能導致閣下申請證券統）香港結算或香港結算代理人；彼等將會就中央結算系統的運作使用有關個人資料；被拒或延遲，或本公司或其香港證券登記處無法 ‧ 向本公司或香港證券登記處提供與其各自業落實轉讓或提供服務。此舉亦可能妨礙或延遲登務營運有關的行政、電訊、電腦、付款或其記或過戶閣下成功申請的香港發售股份及╱或寄他服務的任何代理、承包商或第三方服務供發閣下應得的股票及╱或退款支票。應商； ‧ 聯交所、證監會及任何其他法定監管機構或證券持有人所提供的個人資料如有任何錯誤，須政府部門或法例、規則或規例另行規定者；立即通知本公司及香港證券登記處。及 ‧ 2. 目的 證券持有人與其進行或擬進行交易的任何人士或機構，例如彼等的銀行、律師、會計師證券持有人的個人資料可以任何方式被採用、持或股票經紀等。有、處理及╱或保存，以作下列用途： ‧ 處理閣下的申請及退款支票（如適用）、核 4. 保留個人資料 實是否符合本申請表格及招股章程載列的條本公司及其香港證券登記處將按收集個人資料所款及申請程序以及公佈香港發售股份的分配需的用途保留證券申請人及持有人的個人資料。毋須保留的個人資料將會根據條例銷毀或處理。結果； ‧ 遵守香港及其他地區的適用法例及規例； 5. 查閱及更正個人資料 ‧ 以證券持有人（包括香港結算代理人（如適證券持有人有權確定本公司或香港證券登記處是用））的名義登記新發行證券或轉讓或受讓證否持有其個人資料，並有權索取該資料的副本及券；更正任何不準確資料。本公司及香港證券登記處 ‧ 有權就處理有關要求收取合理費用。存置或更新本公司證券持有人的名冊； ‧ 核實證券持有人的身份；所有查閱資料或更正資料的要求均應按招股章程

所有查閱資料或更正資料的要求均應按招股章程「公司資料」一節所披露或不時通知的本公司註冊地址送交公司秘書，或向本公司香港證券登記處的私隱合規主任提出。

‧ 確定本公司證券持有人的受益權利，例如股息、供股及紅股等；
‧ 分發本公司及其附屬公司的通訊資料；
‧ 編製統計數據及證券持有人資料；

閣下簽署申請表格或向香港結算發出電子認購指示，即表示同意上述各項。

‧ 披露有關資料以便就權益索償；及

AI assistant

Mabpharm Limited Share Issue/Capital Change 2019

50428_rns_2019-05-19_b7233fd5-e9ee-45cb-a615-1d2ed4db552c.pdf

申請人聲明

Applicants’ declaration

How to make your application

申請手續

D. Power of attorney

AI assistant

Mabpharm Limited — Share Issue/Capital Change 2019

50428_rns_2019-05-19_b7233fd5-e9ee-45cb-a615-1d2ed4db552c.pdf

申請人聲明

Applicants’ declaration

How to make your application

申請手續

D. Power of attorney

More from Mabpharm Limited

Mabpharm Limited Share Issue/Capital Change 2019